Importance of Participation in Clinical Trials

Only about 5% of women with a gynecologic cancer participate in the dozens of clinical trials in gynecologic cancers. The predominant hope for improving on the treatment options for women diagnosed with a gynecologic cancer is through the conduct of clinical trials.

The Foundation for Women’s Cancer actively works with the Gynecologic Oncology Group (GOG) to encourage women to participate in clinical trials. Clinical trials are a crucial step in finding new and improved ways to improve treatment for women diagnosed with a gynecologic cancer. Read more…

Spotlight

Staff and supporters at the Foundation are thrilled to welcome new Chairman David Mutch, MD, FACOG. Read Dr. Mutch’s bio here.

Awareness

Unbreakable Bonds: Read this NY Times Mother’s Day tribute featuring Nt’l Race Host Committee member Megan Neforos: click here

Research

The Foundation for Women’s Cancer is pleased to announce the recipients of its 2014-2015 Research Grant and Prizes. View the PDF.

Education

The next Gynecologic Cancer Survivors Course is June 27 in Shreveport, Louisiana. For more information, click here.